Cargando…

Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design

Detalles Bibliográficos
Autores principales: Singh, Udaya Pratap, Singh, Ramendra K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236975/
http://dx.doi.org/10.1186/1742-4690-8-S2-P82
_version_ 1782218824387395584
author Singh, Udaya Pratap
Singh, Ramendra K
author_facet Singh, Udaya Pratap
Singh, Ramendra K
author_sort Singh, Udaya Pratap
collection PubMed
description
format Online
Article
Text
id pubmed-3236975
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32369752011-12-14 Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design Singh, Udaya Pratap Singh, Ramendra K Retrovirology Poster Presentation BioMed Central 2011-10-03 /pmc/articles/PMC3236975/ http://dx.doi.org/10.1186/1742-4690-8-S2-P82 Text en Copyright ©2011 Singh and Singh; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Singh, Udaya Pratap
Singh, Ramendra K
Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design
title Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design
title_full Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design
title_fullStr Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design
title_full_unstemmed Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design
title_short Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design
title_sort molecular docking analysis of novel non-nucleoside reverse transcriptase inhibitors in development: implication for rational drug design
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236975/
http://dx.doi.org/10.1186/1742-4690-8-S2-P82
work_keys_str_mv AT singhudayapratap moleculardockinganalysisofnovelnonnucleosidereversetranscriptaseinhibitorsindevelopmentimplicationforrationaldrugdesign
AT singhramendrak moleculardockinganalysisofnovelnonnucleosidereversetranscriptaseinhibitorsindevelopmentimplicationforrationaldrugdesign